Likewise, the use of amlodipine in spontaneously hypertensive rats with steatohepatitis improved IR, and cytokine profile of IL-6 and IL-10, suggesting that amlodipine could be beneficial for patients with metabolic syndrome and MASH [135]. Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.